Condition: Obesity · Overweight · Sponsor: Novo Nordisk A/S
The purpose of this clinical study is to find out if zenagamtide is safe and effective for treating people who have excess body weight. There are 2 study treatments in this study taken as injections under the skin once a week. Participants will either get zenagamtide (the treatment being tested) or placebo (a treatment that has no active medicine in it). Which treatment participants get is decided by chance.
This description comes directly from the study's public registry record.
Novo Nordisk · (+1) 866-867-7178 · clinicaltrials@novonordisk.com
Always discuss trial participation with your own doctor first.
| Nirmal Hospital Pvt. Ltd. | Surat, Gujarat, India | — |
| SSG Hospital, Baroda | Vadodara, Gujarat, India | — |
| Karnataka Medical College and Research Institute | Hubbali, Karnataka, India | — |
| Government Medical College, Kozhikode | Kozhikode, Kerala, India | — |
| TOTALL Diabetes Hormone Institute | Indore, Madhya Pradesh, India | — |
| Shree Mahalaxmi DIATONE Institute | Kohlapur, Maharashtra, India | — |
| Excel Endocrine Centre | Kolhāpur, Maharashtra, India | — |
| BSES MG hospital | Mumbai, Maharashtra, India | — |
| All India Institute of Medical Sciences (AIIMS), Nagpur | Nagpur, Maharashtra, India | — |
| Shalini Tai Meghe Hospital and Research Center | Nagpur, Maharashtra, India | — |
| Vijan Hospital & Research Centre | Nashik, Maharashtra, India | — |
| Grant Medical Foundation Ruby Hall Clinic | Pune, Maharashtra, India | — |
+ 29 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.